Position in RNXT
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,682,758
+$1,178,758 QoQ
Shares Held
1,666,098
+177.7% QoQ
Ownership
3.70%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RNXT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Bleichroeder LP holds $45,002,103 across 18 Biotechnology names. RNXT ranks #9 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DTIL |
Precision Biosciences Inc
|
1,662,500 | $9,143,750 | |
| 2 | IMMX |
Immix Biopharma, Inc.
|
1,000,000 | $9,110,000 | |
| 3 | EYPT |
EyePoint, Inc.
|
316,515 | $4,079,878 | |
| 4 | PROK |
Prokidney Corp.
|
2,000,000 | $3,580,000 | |
| 5 | IRD |
Opus Genetics, Inc.
|
736,842 | $3,352,631 | |
| 6 | GNLX |
GENELUX Corp
|
1,380,666 | $3,341,211 | |
| 7 | KZIA |
Kazia Therapeutics Ltd
|
400,000 | $2,976,000 | |
| 8 | DMAC |
DiaMedica Therapeutics Inc.
|
382,317 | $2,588,286 |
All Filings in RNXT
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,682,758 | 1,666,098 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $504,000 | 600,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $684,048 | 538,621 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $657,500 | 500,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $495,000 | 500,000 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||